Scientific-related companies are a central component of the Potsdam Science Park. Around 20 companies and start-ups have already decided in favour of this innovative location. Park management’s goal is to attract another 100 small and medium-sized companies and one anchor company to the park over the next ten years. This would create more than 1,000 new jobs in Potsdam-Golm and generate an investment of around 100 million euros. This location will thus become one of the largest areas of growth in Brandenburg.
Production and sale of the plant product artemisinin, artemisinin-derivatives as active pharmaceutical ingredients (APIs), and medications based on artemisinin-derivatives for the treatment of cancer, and other diseases.
BIOCYC provides biochemicals and reagents and offers a variety of services, such as the production and modification of synthetic peptides / protease inhibitors as well as the development and production of recombinant rabbit monoclonal antibodies.
Development of novel machine learning methods focused on the analysis of complex biomedical data. The aim is to identify new biomarkers and drug targets in order to develop both diagnostics and therapies more efficiently.
Digitalisation and optimisation of care processes in the health sector. Development and distribution of the teleassistance system “eGeia active”, which enables patients to do their therapeutic exercises at home.
GlycoUniverse specializes in everything related to the synthesis of oligosaccharides. While catalogue products include versatile building blocks for glycan synthesis, it’s also possible to assemble custom building blocks and oligosaccharides.
As a subsidiary of TGZP, Golm Innovationszentrum GmbH operates GO:IN, a science-oriented innovation and start-up center. It offers optimal conditions for a successful start to young companies from research and development .
Developing digital products to empower microfinance institutions to collect high-quality customer data and efficiently track their contribution to the SDGs at the level of single households.
Hybrotec works in the field of antibody and immunotechnology. Core competencies include the production of monoclonal antibodies and the development of homogeneous and customised immunoassays.
MetaSysX offers analytical services on one of the most comprehensive metabolomics platforms worldwide. In addition, MetaSysX is specializing in complex statistical data analysis and integration with genomic, transcriptomic, proteomic, and phenomic data.
Nanolytics Instruments is dedicated to the development of enhanced detectors for the Analytical Ultracentrifuge. Furthermore, the company produces measurement cells and other AUC accessories.
Development of quantitative ultrasound-based methods for the analysis of cortical bone micro structures as well as the development, construction or (series) production and distribution of corresponding devices for the application of this method, in particular in the medical diagnosis of osteoporosis.
RIPAC-LABOR GmbH produces customised herd-specific vaccines for animals based on the exact identification of the infection-causing pathogens. For this purpose, the company has built up its own extensive pathogen database and strain collection.
targenomix takes a systems biology approach, merging molecular biology, cell biology, genetics, biochemistry, metabolomics and transcriptomics through data integration and computational biology solutions. The focus is on the discovery and validation of small molecule targets.
Technologie- und Gewerbezentren Potsdam GmbH (TGZP) operates industry-oriented technology and start-up centers and offers companies and start-ups space and rooms. For companies from the biotech and life sciences sectors, there are individually combinable offers of office and lab space with the latest technical standards at GO:IN 2.
UP Transfer’s main concern is to complement excellence in research and teaching with a professional transfer of results from science into practice. Service and support is offered in the areas further education, Consulting & Coaching, Research & Development and Event Management.